304 related articles for article (PubMed ID: 333044)
21. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
22. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
23. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683
[TBL] [Abstract][Full Text] [Related]
24. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
25. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
Joseph S; Krishnamurthi S; Kakkar VV
Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
[TBL] [Abstract][Full Text] [Related]
26. XC 386: a new antiplatelet agent.
Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
[TBL] [Abstract][Full Text] [Related]
27. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
Clowes AW; Karnovsky MJ
Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
[TBL] [Abstract][Full Text] [Related]
28. Effects of PGI2 on platelet aggregation induced by various stimulants.
Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
[No Abstract] [Full Text] [Related]
29. Antiplatelet effect of butylidenephthalide.
Teng CM; Chen WY; Ko WC; Ouyang CH
Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
[TBL] [Abstract][Full Text] [Related]
30. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
Tandon NN; Ordinas A; Jamieson GA
Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
[TBL] [Abstract][Full Text] [Related]
31. Role of paf-acether and related ether-lipid metabolism in platelets.
Chignard M; Coëffier E; Benveniste J
Adv Exp Med Biol; 1985; 192():309-26. PubMed ID: 2422886
[No Abstract] [Full Text] [Related]
32. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid.
Davies T; Davidson MM; McClenaghan MD; Say A; Haslam RJ
Thromb Res; 1976 Oct; 9(4):387-405. PubMed ID: 185743
[No Abstract] [Full Text] [Related]
33. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
34. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
Teng CM; Ma YH; Ouyang CH
Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
[TBL] [Abstract][Full Text] [Related]
35. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
[TBL] [Abstract][Full Text] [Related]
36. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
Egger M; Donath E; Spangenberg P; Bimmler M; Glaser R; Till U
Biochim Biophys Acta; 1988 Dec; 972(3):265-76. PubMed ID: 3143424
[TBL] [Abstract][Full Text] [Related]
37. Effects of cryptolepine on collagen-induced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit platelets.
Oyekan AO; Ablordeppey SY
Gen Pharmacol; 1993 Sep; 24(5):1285-90. PubMed ID: 8270188
[TBL] [Abstract][Full Text] [Related]
38. Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets.
Hurst JS; Slater TF; Lang J; Juergens G; Zollner H; Esterbauer H
Chem Biol Interact; 1987 Feb; 61(2):109-24. PubMed ID: 3103933
[TBL] [Abstract][Full Text] [Related]
39. Human platelet aggregation by thimerosal. Functional and ultrastructural studies.
Leone G; Schintu S; Porfiri R; Landolfi R; Bizzi B
Haemostasis; 1979; 8(6):390-9. PubMed ID: 511017
[TBL] [Abstract][Full Text] [Related]
40. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Kornecki E; Ehrlich YH; Lenox RH
Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
